Literature DB >> 26918678

PAK1-cofilin phosphorylation mediates human lung adenocarcinoma cells migration induced by apelin-13.

Deguan Lv1, Lanfang Li1, Qixuan Lu1, Yao Li1, Feng Xie1, Hening Li1, Jiangang Cao1, Meiqing Liu1, Di Wu1, Lu He1, Linxi Chen1.   

Abstract

Adipocytokines apelin peptide, the ligand of APJ (putative receptor related to the angiotensin receptor AT1), plays key roles in the pathogenesis and deterioration of cancer. In lung cancer, apelin elevating microvessel densities has been reported. Our previous research has characterized that apelin-13 promoted lung adenocarcinoma cell proliferation. However, the effect of apelin on metastasis in lung adenocarcinoma and the underlying mechanisms remain unclear. This study shows that apelin-13 induced human adenocarcinoma cell migration via the APJ receptor. Apelin-13 phosphorylated PAK1 and cofilin increase the migration of lung adenocarcinoma cells. Moreover, the results verify that over-expression of apelin and APJ contributed to reducing the effect of doxorubicin and razoxane on inhibiting lung adenocarcinoma cells metastasis. Hypoxia activated APJ expression and apelin release in lung adenocarcinoma cells. The results demonstrate a PAK1-cofilin phosphorylation mechanism to mediate lung adenocarcinoma cells migration promoted by apelin-13. This discovery further suggests that APJ and its downstream signalling is a potential target for anti-metastatic therapies in lung adenocarcinoma patients.
© 2016 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  APJ; PAK1; apelin; cofilin; drug resistance; hypoxia; lung adenocarcinoma; migration

Mesh:

Substances:

Year:  2016        PMID: 26918678     DOI: 10.1111/1440-1681.12563

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  16 in total

Review 1.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

2.  Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity.

Authors:  P Song; B Song; J Liu; X Wang; X Nan; J Wang
Journal:  Clin Transl Oncol       Date:  2020-09-24       Impact factor: 3.405

3.  Amidation-Modified Apelin-13 Regulates PPARγ and Perilipin to Inhibit Adipogenic Differentiation and Promote Lipolysis.

Authors:  Sha Wang; Guoying Gao; Yiwei He; Qiong Li; Zhan Li; Guoxiang Tong
Journal:  Bioinorg Chem Appl       Date:  2021-05-07       Impact factor: 7.778

4.  NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity.

Authors:  Batuer Aikemu; Yanfei Shao; Guang Yang; Junjun Ma; Sen Zhang; Xiao Yang; Hiju Hong; Galiya Yesseyeva; Ling Huang; Hongtao Jia; Chenxing Wang; Lu Zang; Jing Sun; Minhua Zheng
Journal:  Int J Biol Sci       Date:  2021-04-17       Impact factor: 6.580

Review 5.  The Role of the Apelin/APJ System in the Regulation of Liver Disease.

Authors:  Xinrui Lv; Jing Kong; Wei-Dong Chen; Yan-Dong Wang
Journal:  Front Pharmacol       Date:  2017-04-24       Impact factor: 5.810

Review 6.  The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer.

Authors:  Marta B Wysocka; Katarzyna Pietraszek-Gremplewicz; Dorota Nowak
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

7.  Apelin Effects Migration and Invasion Abilities of Colon Cancer Cells.

Authors:  Marta Podgórska; Katarzyna Pietraszek-Gremplewicz; Dorota Nowak
Journal:  Cells       Date:  2018-08-20       Impact factor: 6.600

Review 8.  The role of Elabela in kidney disease.

Authors:  Qian Zheng; Geng Tian; Feng Xu; Xin Ci; Rumei Luan; Linlin Wu; Xuehong Lu
Journal:  Int Urol Nephrol       Date:  2021-03-08       Impact factor: 2.370

9.  A network map of apelin-mediated signaling.

Authors:  Shobha Dagamajalu; D A B Rex; Pushparani Devi Philem; Jan K Rainey; T S Keshava Prasad
Journal:  J Cell Commun Signal       Date:  2021-04-02       Impact factor: 5.782

10.  Apelin Controls Angiogenesis-Dependent Glioblastoma Growth.

Authors:  Anne Frisch; Stefanie Kälin; Raymond Monk; Josefine Radke; Frank L Heppner; Roland E Kälin
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.